Skip to main content
HR 5812 115th Congress House Health Congressional oversight Drug trafficking and controlled substances Drug, alcohol, tobacco use Emergency medical services and trauma care Government studies and investigations Health information and medical records Health programs administration and funding Health promotion and preventive care Hospital care Indian social and development programs Intergovernmental relations Minority health Prescription drugs Right of privacy State and local government operations Veterans' medical care

CONNECTIONS Act

Introduced: May 15, 2018 Introduced by: Griffith, H. Morgan Republican · Virginia See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 11 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 13, 2018
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 12, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 12, 2018
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5071-5073)
Jun 12, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H5071-5073)
Jun 12, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5812.
Jun 12, 2018
Considered under suspension of the rules. (consideration: CR H5071-5074)
Jun 12, 2018
Mr. Walden moved to suspend the rules and pass the bill.
May 17, 2018
Ordered to be Reported by Voice Vote.
May 17, 2018
Committee Consideration and Mark-up Session Held.
May 15, 2018
Referred to the House Committee on Energy and Commerce.
May 15, 2018
Introduced in House
 Plain-English summary Congressional Research Service

Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act of 2018 or the CONNECTIONS Act

This bill authorizes the Centers for Disease Control and Prevention to provide technical assistance and award grants in order to: (1) improve the efficiency and use of state prescription drug monitoring programs (PDMPs), achieve community or health system interventions relating to controlled substances (e.g., prescription guidelines), and promote new approaches to responding to emerging public health crises; and (2) improve the timeliness, comprehensiveness, and usefulness of reported overdose data.

The bill also amends the Public Health Service Act to alter requirements relating to PDMPs. Among other changes, the bill: (1) repeals requirements regarding grant formulas, database standards, and authorized data disclosures; and (2) authorizes federal support for specific improvements regarding use, data reporting, and intrastate and interstate interoperability. The Department of Health and Human Services must report on the progress of states in implementing PDMPs that are consistent with such improvements.

What's happening now June 13, 2018

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 2
 Cosponsors 4
All 4 Democratic 1 Republican 3